A hitherto undescribed feature in the anticonvulsant effect of phenobarbital.
D000109:Acetylcholine / Q000378:metabolism; D000613:Aminobutyrates / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D002262:Carboxy-Lyases / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004597:Electroshock; D005260:Female; D005971:Glutamates / Q000378:metabolism; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism; D010634:Phenobarbital / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D012640:Seizures / Q000517:prevention & control*; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D000613:Aminobutyrates; D005971:Glutamates; D012701:Serotonin; D002262:Carboxy-Lyases; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine; D010634:Phenobarbital